1. Department of Affiliated The First Clinical Medical College of Xuzhou Medical University, Xuzhou 221000 China; 2. Xuzhou Central Hospital, Xuzhou 221000 China
[1] Johnson CA, James D, Marzan A, et al. Cervical cancer: an overview of pathophysiology and management[J]. Semin Oncol Nurs, 2019, 35(2): 166-174. [2] 姜松, 杜傲男, 杨婷婷, 等. 阴道模具预防宫颈癌放射性阴道狭窄的临床研究[J]. 中国辐射卫生,2021,30(2):229-232. Jiang S, Du AN, Yang TT, et al. Clinical study of using constant temperature vaginal mould to prevent radiation vaginal stenosis in patients with cervical cancer treated with radiotherapy[J]. Chin J Radiol Health, 2021, 30(2): 229-232. [3] 宜建英, 刘志礼, 王璐, 等. 晚期宫颈癌的免疫治疗研究进展[J]. 医学理论与实践, 2022, 35(22): 3814-3817. DOI: 10.19381/j.issn.1001-7585.2022.22.011. Yi JY, Liu ZL, Wang L, et al. Research progress in immunotherapy for advanced cervical cancer[J]. J Med Theory Pract, 2022, 35(22): 3814-3817. DOI: 10.19381/j.issn.1001-7585.2022.22.011. [4] 李静, 孔为民. 复发性子宫颈癌的治疗研究进展[J]. 中国妇幼保健, 2023, 38(9): 1743-1746. DOI: 10.19829/j.zgfybj.issn.1001-4411.2023.09.049. Li J, Kong WM. Research progress in the treatment of recurrent cervical cancer[J]. Matern Child Health Care China, 2023, 38(9): 1743-1746. DOI: 10.19829/j.zgfybj.issn.1001-4411.2023.09.049. [5] Zhu HH, Hu J, Lo-Coco F, et al. The simpler, the better: oral arsenic for acute promyelocytic leukemia[J]. Blood, 2019, 134(7): 597-605. [6] 张雅丽, 任金海, 崔丽艳, 等. 三氧化二砷对HL-60细胞增殖、分化和凋亡的影响及其作用机制探讨[J]. 中国实验血液学杂志,2015,23(3):647-652. Zhang YL, Ren JH, Cui LY, et al. Effects of As2O3 on the proliferation, differentiation and apoptosis of HL-60 cells and its related mechanisms[J]. J Exp Hematol, 2015, 23(3): 647-652. [7] He ZY, Li HY, Yan J, et al. A prospective trial to evaluate the clinical efficacy and safety of neoadjuvant chemotherapy with arsenic trioxide and carboplatin in locally advanced cervical cancer: a study protocol for randomized controlled clinical[J]. Trials, 2022, 23(1): 556. [8] 陈洁盈, 陈耀庭, 林泽宇, 等. 三氧化二砷逆转低浓度索拉非尼对人肝癌细胞促迁移作用及其机制[J]. 中华肝脏外科手术学电子杂志,2016,5(2):114-118. Chen JY, Chen YT, Lin ZY, et al. Inhibitory effect and mechanism of arsenic trioxide on human hepatocellular carcinoma cells migration ;induced by low dose of sorafenib[J]. Chin J Hepat Surg (Electron Ed), 2016, 5(2): 114-118. [9] Yu J, Qian HL, Li YF, et al. Arsenic trioxide (As2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo[J]. Gynecol Oncol, 2007, 106(2): 400-406. [10] Cai H, Li XP, Wang JL. Arsenic trioxide in the treatment of platinum-resistant recurrent endometrial cancer: a case report and literature review[J]. J Obstet Gynaecol, 2020, 40(1): 137-138. [11] 陈诚, 刘凯, 纪柏, 等. 丙戊酸钠对人肝癌SMMC-7221细胞的放疗增敏作用研究[J]. 中国辐射卫生,2014,23(1):60-63. Chen C, Liu K, Ji B, et al. Radiosensitization effect of valproic acid on human hepatocellular cell line SMMC- 7221[J]. Chin J Radiol Health, 2014, 23(1): 60-63. [12] 王东东, 刘培, 李阔, 等. 多目标优化在宫颈癌放疗中的临床应用分析[J]. 中国辐射卫生,2022,31(2):219-223. Wang DD, Liu P, Li K, et al. Clinical application of multi-criteria optimization in radiotherapy for cervical cancer[J]. Chin J Radiol Health, 2022, 31(2): 219-223. [13] 田茂叶, 聂红梅, 刘亚, 等. 细胞死亡在辐射防护与放疗增敏中的研究进展[J]. 中国辐射卫生,2023,32(2):216-222. Tian MY, Nie HM, Liu Y, et al. Research progress of cell death in radiation protection and radiosensitization[J]. Chin J Radiol Health, 2023, 32(2): 216-222. [14] 张宇睿, 徐文清. 电离辐射对线粒体损伤的研究进展[J]. 国际放射医学核医学杂志,2016,40(2):154-158. Zhang YR, Xu WQ. Damages of ionizing radiation on mitochondria[J]. Int J Radiat Med Nucl Med, 2016, 40(2): 154-158. [15] 余小玲, 荣利, 方芳, 等. 低剂量X线辐射对A549细胞凋亡的适应性反应[J]. 中国辐射卫生,2022,31(2):139-143,148. Yu XL, Rong L, Fang F, et al. Adaptive response of A549 cell apoptosis induced by low-dose X-ray irradiation[J]. Chin J Radiol Health, 2022, 31(2): 139-143,148. [16] Jiang ML, Jia KY, Wang L, et al. Alterations of DNA damage repair in cancer: from mechanisms to applications[J]. Ann Transl Med, 2020, 8(24): 1685. [17] 冉曦, 肖春江, 冉新泽. 腹盆腔放射治疗的并发症及其防治研究[J]. 中国辐射卫生, 2017, 26(2): 249-253. DOI: 10.3969/j.issn.1004-714X.2017.02.040. Ran X, Xiao CJ, Ran XZ. Complications of abdominopelvic radiotherapy and its prevention and treatment[J]. Chin J Radiol Health, 2017, 26(2): 249-253. DOI: 10.3969/j.issn.1004-714X.2017.02.040. [18] Chun YJ, Park IC, Park MJ, et al. Enhancement of radiation response in human cervical cancer cells in vitro and in vivo by arsenic trioxide (As2O3)[J]. FEBS Lett, 2002, 519(1/3): 195-200. [19] 莫琳. 抑癌基因PTEN在同源重组修复及其敲除对Rad51基因表达的影响及机制研究[D]. 重庆: 重庆医科大学, 2009. Mo L. Study on the effect of PTEN on homologous recombination rapair, Rad51 and its mechanism[D]. Chongqing: Chongqing Medical University, 2009. [20] Adiga D, Eswaran S, Pandey D, et al. Molecular landscape of recurrent cervical cancer[J]. Crit Rev Oncol Hematol, 2021, 157: 103178. [21] 张艳明, 张东峰. 放化疗联合治疗中晚期宫颈癌64例疗效观察[J]. 中国辐射卫生, 2011, 20(2): 245-246. DOI: 10.13491/j.cnki.issn.1004-714X.2011.02.068. Zhang YM, Zhang DF. Diagnosis and treatment chem - and radio - therapy obsevation of cases of mid - and late - stage cervical cancer on thuerapulic effect[J]. Chin J Radiol Health, 2011, 20(2): 245-246. DOI: 10.13491/j.cnki.issn.1004-714X.2011.02.068. [22] Jiang P, Zou LJ, Wei LC, et al. Chinese expert consensus on Iodine125 seed implantation for recurrent cervical cancer in 2021[J]. Front Oncol, 2021, 11: 700710. [23] Yu J, Qian HL, Li YF, et al. Therapeutic effect of arsenic trioxide (As2O3) on cervical cancer in vitro and in vivo through apoptosis induction[J]. Cancer Biol Ther, 2007, 6(4): 580-586. [24] Wang GB, Liu JH, Hu J, et al. Mechanism of As2O3 induces apoptosis of glioma U87 cells[J]. Eur Rev Med Pharmacol Sci, 2017, 21(21): 4875-4881. [25] Hoonjan M, Jadhav V, Bhatt P. Arsenic trioxide: insights into its evolution to an anticancer agent[J]. J Biol Inorg Chem, 2018, 23(3): 313-329. [26] 汪选斌, 柯静, 王家宁, 等. 三氧化二砷联合5-氟尿嘧啶对人大肠癌SW480细胞的抑制作用[J]. 郧阳医学院学报,2007,26(5):278-280. Wang XB, Ke J, Wang JN, et al. The inhibitory effect of fluorouracil combined with arsenic trioxide on human colorectal cells SW480 by MTT[J]. J Yunyang Med Coll, 2007, 26(5): 278-280. [27] Mansour WY, Tennstedt P, Volquardsen J, et al. Loss of PTEN-assisted G2/M checkpoint impedes homologous recombination repair and enhances radio-curability and PARP inhibitor treatment response in prostate cancer[J]. Sci Rep, 2018, 8(1): 3947. [28] Sinha A, Saleh A, Endersby R, et al. RAD51-mediated DNA homologous recombination is independent of PTEN mutational status[J]. Cancers, 2020, 12(11): 3178. [29] Pei XL, Mladenov E, Soni A, et al. PTEN loss enhances error-prone DSB processing and tumor cell radiosensitivity by suppressing RAD51 expression and homologous recombination[J]. Int J Mol Sci, 2022, 23(21): 12876. [30] 蒋超, 张鹏程, 王晓炜, 等. 二甲双胍对肺癌细胞A549放疗增敏作用及机制研究[J]. 中国辐射卫生,2017,26(6):718-722. Jiang C, Zhang PC, Wang XW, et al. Sensitizing effect and Mechanism of metformin on radiotherapy of lung carcinoma A549 cells[J]. Chin J Radiol Health, 2017, 26(6): 718-722.